Clinical Research
Off-shoring: A Country Attractiveness Index for Clinical Trials
By Mark P. Mathieu
For many years, pharmaceutical companies have been off-shoring manufacturing operations to lower-cost countries. Healthy margins and strong risk aversion have afforded pharmaceutical companies the luxury of staying close to home, for all but manufacturing activities. As financial pressures increase, pharmaceutical executives are finding that going offshore is not only less risky than it once was, but also too attractive to ignore. Read More
|
|
ADAPT 2011
The benefits to the patient, as well as the business opportunities a targeted therapy approach present are driving this change. The ADAPT 2011 Congress brings together senior executives and key strategic players from across Pharma, Diagnostic, Clinical and Informatics to work together to shape the future of personalized medicine towards a targeted approach. Case studies, discussion groups, short courses and technology highlights will explore the relationship between biomarkers and the promise of personalized therapy, how circulating tumor cells (CTCs) could better track the progression of cancer, and adaptive trials that bring targeted therapies to market.
For more information & to register, visit: www.adaptcongress.com
May 21-23, 2012
Philadelphia, PA
June 4-7, 2012
Boston, MA
June 4-5, 2012
Boston, MA
June 4-5, 2012
Boston, MA
June 6-7, 2012
Boston, MA
June 6-7, 2012
Boston, MA
June 5, 2012
Boston, MA
June 6, 2012
Boston, MA
Barnett Web Seminars
May 17, 2012
May 18, 2012
May 21, 2012
May 23, 2012
May 24, 2012
May 25, 2012
May 29, 2012
May 30, 2012
May 31, 2012
May 31, 2012
June 1, 2012
June 1, 2012
June 4, 2012
June 4, 2012
June 4, 2012
June 5, 2012
June 6, 2012
June 6, 2012
June 6 - August 22, 2012
June 7, 2012
June 8, 2012
June 8, 2012
June 11, 2012
June 11, 2012
June 11, 2012
June 11, 2012
June 12, 2012
June 13, 2012
June 14, 2012
June 15, 2012
June 15, 2012
June 18, 2012
June 18, 2012
June 19, 2012
June 20, 2012
June 21, 2012
June 21, 2012
June 22, 2012
June 22, 2012
June 25, 2012
June 26, 2012
June 27, 2012
June 27, 2012
June 28, 2012
June 29 - August 31, 2012
June 29, 2012
July 26 - October 4, 2012
Barnett Live Seminars
June 4-5, 2012
Boston, MA
June 4-5, 2012
Boston, MA
June 6-7, 2012
Boston, MA
June 7-8, 2012
Boston, MA
June 11-12, 2012
Boston, MA
June 11-12, 2012
Boston, MA
June 13-15, 2012
Boston, MA
June 14-15, 2012
Philadelphia, PA
June 14-15, 2012
Boston, MA
June 14-15, 2012
Boston, MA
June 18-20, 2012
Philadelphia, PA
June 18-19, 2012
Philadelphia, PA
June 20-21, 2012
Philadelphia, PA
June 22, 2012
Boston, MA
June 25-26, 2012
San Francisco, CA
June 25-26, 2012
Boston, MA
June 28-29, 2012
Boston, MA
June 28-29, 2012
Boston, MA
June 28-29, 2012
Philadelphia, PA
June 28-29, 2012
Philadelphia, PA
To have your event featured here, contact Lisa Scimemi for more information.
Sites and Sponsors: Mending Bridges over Troubled Waters
Sponsored by Medidata Solutions Worldwide
This podcast brings together two industry leaders to focus on the issues that divide sponsors and sites. On the one hand sites and sponsors unite in advancing better health care through a common passion for developing better drugs. Yet some issues divide them and bridges need to be built or mended to advance the highest levels of cooperation, coordination and success in clinical trials. Listen as the key issues are debated from the site and the sponsor side and new methods and technology are advanced that offer near-term and lasting solutions.
• Common ground in reaching agreement on a budget
• Improving the pace of agreement on budgets and contracts
• Processes for payment to sites on a timely basis
Listen Now
More Podcasts
|
|
|